University of Vermont
Alex Abuin is an accomplished professional with extensive experience in the biopharmaceutical industry and academic research. Currently serving as the Director of R&D and Professor of the Practice at Eshelman Innovation, Alex focuses on translating novel therapeutic approaches into early-stage assets. As a Research Assistant Professor at the University of Vermont, Alex is a founding advisory board member of the SPARK program, which integrates biomedical research with market innovation. Previous roles include Executive Director of Portfolio Management at Nurix, Inc., and Director of Strategic Industry Ventures at MD Anderson Cancer Center, where Alex facilitated partnerships to advance cancer treatments. Alex's career also encompasses significant positions at Lexicon Pharmaceuticals and SmithKline Beecham Pharmaceuticals, with a solid educational foundation in Molecular and Human Genetics from Baylor College of Medicine and a Bachelor’s degree in Biology from the University of North Carolina at Charlotte.
This person is not in any teams
This person is not in any offices
University of Vermont
2 followers
Since 1791, the University of Vermont has worked to move humankind forward. Today, UVM is a Public Ivy and top research university of a perfect size, large enough to offer a breadth of ideas, resources, and opportunities, yet small enough to enable close faculty-student mentorship across all levels of study, from bachelor's to M.D. programs.